Brooklyn Gillit, FNP-C | |
1680 Antilley Rd Ste 270, Abilene, TX 79606-5247 | |
(325) 428-4790 | |
Not Available |
Full Name | Brooklyn Gillit |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Experience | 4 Years |
Location | 1680 Antilley Rd Ste 270, Abilene, Texas |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1518639624 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363LF0000X | Nurse Practitioner - Family | F09201229 (Texas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Hendrick Medical Center | Abilene, TX | Hospital |
Brownwood Regional Medical Center | Brownwood, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Hendrick Provider Network | 9739162181 | 231 |
News Archive
Jennerex, Inc. (San Francisco, CA and Ottawa, Ontario), a clinical stage biotherapeutics company developing a proprietary breakthrough product class of targeted oncolytic virus therapeutics, today announced that the European Medicines Agency (EMEA) has granted Orphan Drug Designation to Jennerex's product JX-594 for the treatment of hepatocellular carcinoma (HCC), the most common form of liver cancer. JX-594 is expected to enter a Phase 3 pivotal trial in the second half of 2010.
Overblown fears about surgical risk and lack of awareness about the risk of not operating are among the reasons only half of eligible patients were referred for mitral valve repair, according to a study by doctors at the University of Michigan Cardiovascular Center.
Have you ever thought someone was angry at you, but it turned out you were just misreading their facial expression? Caltech researchers have now discovered that one specific region of the brain, called the amygdala, is involved in making these (sometimes inaccurate) judgments about ambiguous or intense emotions.
Concert Pharmaceuticals, Inc. today announced 48-week results of its Phase 2 clinical trial of CTP-499 in patients with diabetic kidney disease. CTP-499, when used in addition to the standard of care, is being developed to delay the progression of these patients to end-stage renal failure, which requires dialysis or kidney transplantation.
› Verified 7 days ago
Entity Name | Hendrick Provider Network |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1396961322 PECOS PAC ID: 9739162181 Enrollment ID: O20040609001047 |
News Archive
Jennerex, Inc. (San Francisco, CA and Ottawa, Ontario), a clinical stage biotherapeutics company developing a proprietary breakthrough product class of targeted oncolytic virus therapeutics, today announced that the European Medicines Agency (EMEA) has granted Orphan Drug Designation to Jennerex's product JX-594 for the treatment of hepatocellular carcinoma (HCC), the most common form of liver cancer. JX-594 is expected to enter a Phase 3 pivotal trial in the second half of 2010.
Overblown fears about surgical risk and lack of awareness about the risk of not operating are among the reasons only half of eligible patients were referred for mitral valve repair, according to a study by doctors at the University of Michigan Cardiovascular Center.
Have you ever thought someone was angry at you, but it turned out you were just misreading their facial expression? Caltech researchers have now discovered that one specific region of the brain, called the amygdala, is involved in making these (sometimes inaccurate) judgments about ambiguous or intense emotions.
Concert Pharmaceuticals, Inc. today announced 48-week results of its Phase 2 clinical trial of CTP-499 in patients with diabetic kidney disease. CTP-499, when used in addition to the standard of care, is being developed to delay the progression of these patients to end-stage renal failure, which requires dialysis or kidney transplantation.
› Verified 7 days ago
Entity Name | Hpn Physician Billing, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1538656186 PECOS PAC ID: 7315357191 Enrollment ID: O20201105002661 |
News Archive
Jennerex, Inc. (San Francisco, CA and Ottawa, Ontario), a clinical stage biotherapeutics company developing a proprietary breakthrough product class of targeted oncolytic virus therapeutics, today announced that the European Medicines Agency (EMEA) has granted Orphan Drug Designation to Jennerex's product JX-594 for the treatment of hepatocellular carcinoma (HCC), the most common form of liver cancer. JX-594 is expected to enter a Phase 3 pivotal trial in the second half of 2010.
Overblown fears about surgical risk and lack of awareness about the risk of not operating are among the reasons only half of eligible patients were referred for mitral valve repair, according to a study by doctors at the University of Michigan Cardiovascular Center.
Have you ever thought someone was angry at you, but it turned out you were just misreading their facial expression? Caltech researchers have now discovered that one specific region of the brain, called the amygdala, is involved in making these (sometimes inaccurate) judgments about ambiguous or intense emotions.
Concert Pharmaceuticals, Inc. today announced 48-week results of its Phase 2 clinical trial of CTP-499 in patients with diabetic kidney disease. CTP-499, when used in addition to the standard of care, is being developed to delay the progression of these patients to end-stage renal failure, which requires dialysis or kidney transplantation.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Brooklyn Gillit, FNP-C 1680 Antilley Rd Ste 270, Abilene, TX 79606-5247 Ph: (325) 428-4790 | Brooklyn Gillit, FNP-C 1680 Antilley Rd Ste 270, Abilene, TX 79606-5247 Ph: (325) 428-4790 |
News Archive
Jennerex, Inc. (San Francisco, CA and Ottawa, Ontario), a clinical stage biotherapeutics company developing a proprietary breakthrough product class of targeted oncolytic virus therapeutics, today announced that the European Medicines Agency (EMEA) has granted Orphan Drug Designation to Jennerex's product JX-594 for the treatment of hepatocellular carcinoma (HCC), the most common form of liver cancer. JX-594 is expected to enter a Phase 3 pivotal trial in the second half of 2010.
Overblown fears about surgical risk and lack of awareness about the risk of not operating are among the reasons only half of eligible patients were referred for mitral valve repair, according to a study by doctors at the University of Michigan Cardiovascular Center.
Have you ever thought someone was angry at you, but it turned out you were just misreading their facial expression? Caltech researchers have now discovered that one specific region of the brain, called the amygdala, is involved in making these (sometimes inaccurate) judgments about ambiguous or intense emotions.
Concert Pharmaceuticals, Inc. today announced 48-week results of its Phase 2 clinical trial of CTP-499 in patients with diabetic kidney disease. CTP-499, when used in addition to the standard of care, is being developed to delay the progression of these patients to end-stage renal failure, which requires dialysis or kidney transplantation.
› Verified 7 days ago
Jewel Monique Trancoso, APRN, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2600 Ivanhoe Ln Apt 204, Abilene, TX 79605 Phone: 325-513-7293 | |
Brandon M. Goetz, N.P. Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1900 Pine St, Abilene, TX 79601 Phone: 325-670-2151 Fax: 405-321-4603 | |
Ana Maria Argumaniz, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1749 Pine St, Abilene, TX 79601 Phone: 325-696-0600 | |
Lauren Brooke Terrell, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 950 N 19th St Ste 200, Abilene, TX 79601 Phone: 325-670-5320 Fax: 325-670-5324 | |
Ms. Elizabeth Webber, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 818 Lexington Ave, Abilene, TX 79605 Phone: 325-696-0212 | |
Richard Sankara Musonera, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1749 Pine St, Abilene, TX 79601 Phone: 325-696-0600 Fax: 325-676-3873 | |
Bailey Ann Estes, APRN-CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1210 N 18th St, Abilene, TX 79601 Phone: 325-207-4734 |